Eli Lilly just struck a major deal with the world's largest retailer. GLP-1 drugs may have uses beyond obesity and diabetes ...
Discover how Novo Nordisk's pipeline is being restructured to refocus its efforts on high-growth areas like diabetes and ...
Anavex (AVXL) awaits a key EU ruling on its Alzheimer’s drug. Learn about trial challenges, approval risks, and why a Sell ...
Zacks Investment Research on MSN
Why Eli Lilly (LLY) is a Top Growth Stock for the Long-Term
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. Featuring daily updates of ...
The summit unites global leaders focused on turning ideas into action and fostering partnerships for lasting impact in health.
New blood tests could help doctors diagnose Alzheimer's disease faster and more accurately, researchers reported Sunday – but ...
The Trump administration is negotiating an agreement with pharmaceutical companies Novo Nordisk and Eli Lilly to offer some of their weight loss drugs at a lower price through TrumpRx.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback